NYSE:DHRLife Sciences
Danaher’s 19.6% Rally Sparks Debate After Portfolio Moves and Diagnostics Growth in 2025
If you have been eyeing Danaher stock lately and wondering what to do next, you are certainly not alone. It is one of those names that frequently finds itself at the center of investor debates, especially after sharp price swings. Over the last month, Danaher has bounced back with an impressive 19.6% gain, recouping much of the ground lost earlier this year. In a shorter timeframe, just in the past week, the stock is up another 6.1%. Despite those recent gains, the year-to-date total return...